Company | Name | Exchange | Sector | Industry | 3 Month | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D Wave Quantum | NYSE | Technology | Software & IT Services | 102.8% | $3.82B | -22x | 1.78 | $13.15 | 7.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.1% Upside | Upgrade to Pro+ | |
Septerna | NASDAQ | Healthcare | Biotechnology & Medical Research | 43.2% | $445.58M | -2.6x | 0.05 | $9.97 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pinetree Capital | OTC Markets | Financials | Investment Banking & Investment Services | 41.5% | $128.38M | 5.6x | 0.07 | $13.25 | 4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Keros | NASDAQ | Healthcare | Biotechnology & Medical Research | 33.2% | $573.90M | 128.6x | 1.33 | $14.10 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kuros Biosciences | OTC Markets | Healthcare | Biotechnology & Medical Research | 32.3% | $1.08B | -231.6x | -3.54 | $30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DeFi Tech | NASDAQ | Technology | Financial Technology (Fintech) & Infrastructure | 26.3% | $1.23B | 80.7x | 0.43 | $3.85 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ascentage Pharma | NASDAQ | Healthcare | Biotechnology & Medical Research | 22.4% | $2.01B | -30.1x | -0.59 | $23.78 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.6% Upside | Upgrade to Pro+ | |
Better Home Finance Holding | NASDAQ | Financials | Banking Services | 20.2% | $209.04M | -1x | -0.01 | $13.73 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SANUWAVE | NASDAQ | Healthcare | Healthcare Equipment & Supplies | 17.9% | $252.18M | -5.3x | -0.45 | $29.58 | -8.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Regenxbio Inc | NASDAQ | Healthcare | Biotechnology & Medical Research | 17.3% | $488.06M | -3.1x | -0.06 | $9.80 | 10.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
LandBridge Co LLC | NYSE | Energy | Oil & Gas | 16.9% | $6.46B | 3,113.2x | -32.92 | $84.39 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.1% Downside | Upgrade to Pro+ | |
Abacus Life | NASDAQ | Financials | Insurance | 16.6% | $854.58M | -38.6x | 0.01 | $8.91 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ARS Pharmaceuticals | NASDAQ | Healthcare | Biotechnology & Medical Research | 15.5% | $1.39B | -87.8x | -1.24 | $14.26 | 4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Arcutis | NASDAQ | Healthcare | Pharmaceuticals | 12.8% | $1.74B | -13.9x | -0.21 | $14.64 | 3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.5% Upside | Upgrade to Pro+ | |
Freedom | NASDAQ | Financials | Investment Banking & Investment Services | 12.4% | $10.94B | 33.1x | -6.27 | $180.28 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Himalaya Shipping | NYSE | Industrials | Freight & Logistics Services | 11.5% | $270.48M | 9.6x | 0.01 | $5.58 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
EverQuote A | NASDAQ | Technology | Software & IT Services | 11.2% | $866.67M | 22.1x | 0.13 | $23.99 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.5% Upside | Upgrade to Pro+ | |
Hims Hers Health | NYSE | Healthcare | Healthcare Providers & Services | 10.5% | $13.94B | 82.4x | 0.01 | $62.34 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -31.1% Downside | Upgrade to Pro+ | |
Blueprint Medicines Corp | NASDAQ | Healthcare | Biotechnology & Medical Research | 10% | $6.52B | -41x | -0.88 | $101.22 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.1% Upside | Upgrade to Pro+ | |
Nuscale Power | NYSE | Utilities | Electrical Utilities & IPPs | 9.7% | $6.87B | -17x | 0.47 | $24.52 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.7% Upside | Upgrade to Pro+ | |
Dividend 15 Split | OTC Markets | Financials | Investment Banking & Investment Services | 8.8% | $561.57M | 1.8x | $4.23 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Genfit | NASDAQ | Healthcare | Biotechnology & Medical Research | 8.5% | $208.37M | 122.4x | 1.18 | $4.18 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cibus | NASDAQ | Healthcare | Healthcare Equipment & Supplies | 8% | $96.96M | -0.3x | -0.01 | $3.12 | 10.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
XOMA | NASDAQ | Consumer Cyclicals | Media & Publishing | 7.4% | $327.29M | -37.8x | -0.46 | $27.48 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CureVac NV | NASDAQ | Healthcare | Biotechnology & Medical Research | 5.7% | $871.35M | 4.7x | 0.03 | $3.86 | 3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.1% Upside | Upgrade to Pro+ | |
Avadel Pharma | NASDAQ | Healthcare | Pharmaceuticals | 5.5% | $871.62M | -34.3x | -0.39 | $9.34 | 3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
RIT Capital Partners | OTC Markets | Financials | Collective Investments | 5.4% | $3.54B | 9x | 0.02 | $25.83 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Delcath Systems | NASDAQ | Healthcare | Healthcare Equipment & Supplies | 4.5% | $630.35M | -39x | -0.51 | $18.10 | 5.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.5% Upside | Upgrade to Pro+ | |
Sprott Physical Gold and Silver Trust | NYSE | Financials | Collective Investments | 4% | $5.70B | 3.5x | $28.45 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Canoe EIT Income Fund | OTC Markets | Financials | Collective Investments | 3.6% | $2.03B | 4.4x | $11.08 | -0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
KKR Real Estate Finance Trust | NYSE | Real Estate | Residential & Commercial REITs | 2.9% | $645.52M | 54.6x | 0.42 | $19.60 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Invesco Mortgage Pref | NYSE | Real Estate | Residential & Commercial REITs | 2.6% | $508.09M | 16x | 0.11 | $24.70 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
XOMA | NASDAQ | Consumer Cyclicals | Media & Publishing | 2.3% | $322.99M | -36.6x | -0.46 | $25.41 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Robinhood Markets | NASDAQ | Technology | Financial Technology (Fintech) & Infrastructure | 2.2% | $56.71B | 35.3x | 0.03 | $64.27 | 4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.6% Upside | Upgrade to Pro+ | |
Annaly | NYSE | Real Estate | Residential & Commercial REITs | 2.2% | $12.02B | 21.1x | 0.12 | $25.65 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eagle Point Prf A | NYSE | Financials | Collective Investments | 1.9% | $360.06M | 8x | $24.18 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Annaly Capital Management Pref | NYSE | Real Estate | Residential & Commercial REITs | 1.9% | $11.95B | 21x | 0.12 | $25.77 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Elron Electronic Industries | OTC Markets | Financials | Investment Banking & Investment Services | 1.4% | $60.74M | 2.7x | 0.01 | $1.15 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gold Royalty | NYSE | Financials | Investment Banking & Investment Services | 1.4% | $274.48M | -79.3x | -0.89 | $1.61 | 7.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Financial 15 | OTC Markets | Financials | Collective Investments | 1.2% | $395.27M | 1.6x | $6.46 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Nuveen Preferredome Opportun Closed | NYSE | Financials | Collective Investments | 1.1% | $2.53B | 6.6x | $7.87 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Coinbase Global | NASDAQ | Technology | Financial Technology (Fintech) & Infrastructure | 0.7% | $67.64B | 45x | 9.05 | $263.99 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.1% Downside | Upgrade to Pro+ | |
Stoke Therapeutics | NASDAQ | Healthcare | Biotechnology & Medical Research | 0.5% | $535.60M | 11.3x | 0.08 | $9.83 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellectis | NASDAQ | Healthcare | Biotechnology & Medical Research | 0.3% | $108.71M | -2.4x | -0.03 | $1.55 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PennyMac Financial | NYSE | Financials | Banking Services | 0.3% | $5.21B | 14.7x | 0.12 | $100.52 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.3% Upside | Upgrade to Pro+ | |
Nexpoint | NYSE | Real Estate | Residential & Commercial REITs | 0.2% | $344.24M | 5.4x | 0.01 | $15.10 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.2% Upside | Upgrade to Pro+ | |
FC Investment Trust | OTC Markets | Financials | Collective Investments | 0% | $7.10B | 5.5x | 0.06 | $13.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
MFA Financial | NYSE | Real Estate | Residential & Commercial REITs | -0.3% | $1.01B | 9.7x | 0 | $24.36 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Saba Capital Income Opportunities Fund | NYSE | Financials | Collective Investments | -0.5% | $323.22M | 8.7x | $7.62 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Annaly Capital Pref G | NYSE | Real Estate | Residential & Commercial REITs | -0.5% | $12.02B | 21.1x | 0.12 | $24.91 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |